Investor Presentation • Jan 31, 2024
Investor Presentation
Open in ViewerOpens in native device viewer
CORPORATE PRESENTATION Jan 2024- Milan
• Prof. Enrico Zio – Scientific Director - Top 2% most influential scientists worldwide according to Stanford University
• Matteo Bregonzio – CTO
INTRODUCING
Datrix team embodies a rich spectrum of expertise, spanning the rigor of science and technology, the strategic insight of economics, and the profound depth of humanistic knowledge. This interdisciplinary approach helps us to craft solutions with a holistic understanding of the complex, multifaceted world we navigate.
Datrix is an international Group developing AI applications to accelerate companies' sustainable growth through data.
DATRIX IS LISTED ON EURONEXT GROWTH MILAN
Datrix mission is to bring AI into vertical markets through Tech Companies that are hyper-specialized in software, enabling platforms and human capabilities.
Our tech companies purpose is to support business people tackling contemporary challenges with applications based on data science and artificial intelligence.
| 2010 | 2017/8 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| Former Google Executives leave a Top Tech Corporation to launch a new Data Driven Venture. |
Angel Investors €2.0M |
2 successful M&As |
Constitution of Datrix Group Equity from VC & Family Office €2.4M |
Equity from industrial partners €2.5M 1 successful M&A to enter the US market IPO on Euronext Growth €15M AuCap |
1 Successful M&A Launch of Aramix Market Entry: MENA REGION |
Innovation Network and R&D Partners
Generative AI tools are set to fuel a decade-long market expansion to \$1.3T by 2032 from \$40 billion last year.
Source: Bloomberg Intelligence, IDC (2023)
Source: BlueWeave Consulting (2023)
Datrix is focused on some very high-growth market segments that apply AI systems to business activities:
Datrix has harnessed the power of EU-funded international projects to develop a proprietary suite of technological assets, showcasing commitment to R&D excellence and innovative growth
| HEALTHCARE & LIFE SCIENCE PROJECTS | CYBERSECURITY PROJECTS | |||||||
|---|---|---|---|---|---|---|---|---|
| Crimson | OrganVision | NewMed | ConCISE | Better | CS-Aware | CS-Aware Next | CybersecH | |
| Transforming cancer diagnosis treatments with an innovative imaging technology at the cellular and tissue levels. |
Advancing personalized cardiac care with AI-integrated, real time analysis of living heart organoids. |
Creating innovative deep learning, photonics, and nanotechnology methods for diagnosing and treating cancer, and heart conditions |
Innovating biomedical optical imaging by creating integrated devices that prioritize data quality over quantity. |
Implementing federated learning, this project facilitates secure, GDPR-compliant health data exchange across 7 global hospitals, utilizing customized AI for superior analysis |
Developed an affordable Cyber Security solution for public administrations. |
Enhancing cybersecurity and proactive risk management using AI to analyze data from threat intelligence and social media. |
Developing the first Europe's end-to end cybersecurity solution specifically designed against Artificial Intelligence Attacks. |
|
| PROPRIETARY TECH ASSETS | ||||||||
| Federated learning system |
||||||||
| Imaging analysis platform |
||||||||
| Cybersecurity platform |
||||||||
| A Big Data ecosystem to handle external & proprietary datasets |
AMBITION – Making AI Competition irrelevant, by exploiting it as a complementary launchpad for our own vertical growth
Datrix stands out in the competitive landscape by 1) offering vertically integrated solutions tailored to specific industry needs and 2) embedding advanced AI models into every application, ensuring that clients capture actionable, relevant and scalable insights.
This two-pronged approach on vertical application and cutting-edge AI sets Datrix apart as a leading AI pure player for the modern enterprise.
AI FOR INDUSTRIAL & BUSINESS PROCESSES
EMPOWERING DIGITAL TRANSFORMATION: FROM DEEP LEARNING TO CLOUD INFRASTRUCTURES & BEYOND
DATRIX'S SUCCESS STORY IN FUNDED INNOVATIVE PROJECTS - Ordered by Project Starting data
The Group takes on the role of coordinator for a new EU-funded project focused on AI for Healthcare
Overall Budget: 10M EUR -> Datrix 1.2M EUR Duration: 3.5 years
BETTER (acronym for BETTER REAL-WORLD HEALTH-DATA DISTRIBUTED ANALYTICS RESEARCH PLATFORM) aims to create an easily accessible platform for European hospital doctors to view real patient data, sortable by condition and genetic parameters.
It also allows for training predictive models, all in full compliance with strict privacy regulations related to healthcare information, thanks to approaches like 'federated learning' and 'distributed AI'.
DRIVING RAPID AND SUSTAINABLE GROWTH
01 ORGANIC GROWTH
Datrix is focused on market expansion that leverages on 3 pillars:
Positioning Datrix cross-area solutions to mid-large enterprises through an highly qualified sales force.
Positioning specific Datrix solutions to SMBs through remote sales teams.
Identifying selected external partners enabling scalable and international distribution of Datrix solutions.
#2 - M&A
Accelerate entry into new markets and/or to strengthen the value chain positioning while simultaneously proactively fostering the growth of target companies.
Accelerate tech and product pipeline development by incorporating technologies, capabilities and expertise that are crucial in driving innovative solutions.
#2 - M&A TARGET COMPANIES PROFILE
Datrix proactively scouts, maps and curates a long pipeline of target companies operating in niche markets or hyperspecialised segments. Targets are:
68 Target in DB and 20 in shortlist
Datrix's distinctive advantage lies in its central leadership team, encompassing innovation, strategy and outstanding tech expertise.
The leadership team shapes the vision and growth roadmap of the companies as well as strategic decisions and actions to elevate their go-to-market. This allows individual companies to stay focused on product development, service delivery and other day-to-day operations.
ByTek is a cutting-edge tech company that harnesses the
power of data analysis, artificial intelligence, proprietary
technologies and human expertise to unlock the true
business potentials of companies
ByTek's REAL fusion of marketing expertise, ad-tech and data science empowers businesses to simplify data-driven decisions, gain a deeper understanding of their target audience, activate/testing marketing actions and drive tangible business growth
With a focus on 1° party/alternative data outcome-based incentives, defined metrics, transparent reporting, and continuous optimization, ByTek accelerate meaningful business impact
Adapex is a full-service monetization platform that helps
publishers and app developers maximize their ad
revenue across multiple channels – Web, Mobile, CTV –
through data.
Adapex has been recognized by Deloitte as one of the fastestgrowing companies and awarded as adtech & programmatic innovator in US (Drum Award, Digiday Media Award, Stevie Award, Inc 5000, etc.).
Its combination of award-winning technology, AI-algorithms and expert ad-ops professionals stands out in the competitive landscape and have been driving revenue lifts of 40-520% for all its partners, across different channels – Web, Mobile, CTV
Aramix harnesses the most advanced descriptive, predictive and prescriptive data science models to improve the efficiency of industrial and management processes across various industries and company sizes
Aramix is the fusion between Aramis hard expertise in physical industrial processes and 3rdPlace multidisciplinary skills/technology to extract knowledge from traditional and alternative data.
This unique fusion accelerates the capacity to win complex industrial / management challenges and to maximize efficiency for international companies.
BUSINESS AREA: ML INDUSTRIAL
TECHNOLOGY & DATA SCIENCE ASSETS
APPLICATIONS: Computer Vision, Predictive Controller, Scheduling, Clustering, RPA, etc.
METHODS: Neural Networks, K-Means, NLP, LLM, Storm Algorithms, Long-Short term Memory, Support Vector Machine, Random Forest, Etc.
FinScience combines alternative data and AI to generate
high-value insights/metrics for thematic investing and
direct indexing generate helping private and institutional
investors to make better-informed decisions.
By incorporating alternative data, Finscience aims to gain a comprehensive while unconventional view of the market and identify investment opportunities that traditional data sources may overlook.
Finscience leverages AI technologies, such as machine learning and natural language processing as well as proprietary metrics to analyse vast amounts of data and extract hidden meaningful patterns, relationships, and insights
These insights include identifying specific companies or sectors driving thematic trends and support investors in constructing portfolios that align with their investment themes.
| SPECIFIC GTM IMPLEMENTATION |
||||
|---|---|---|---|---|
| TARGET | SMEs AND LARGE COMPANIES |
LARGE COMPANIES |
SMEs AND LARGE COMPANIES |
SMEs AND LARGE COMPANIES |
| SALES CHANNEL | • DIRECT • INDIRECT • PARTNERSHIP |
• DIRECT • PARTNERSHIP |
• DIRECT • INDIRECT • PARTNERSHIP |
• DIRECT • PARTNERSHIP |
| REVENUE MODEL |
• REVENUE SHARE |
• SETUP + LICENCE • SOLUTION-AS-A SERVICE • DATA-AS-A SERVICE |
• SETUP + LICENCE • OUTCOME BASED • DATA-AS-A SERVICE |
• DATA-AS-A SERVICE |
Note: size of bubbles are relative to 2023E sales (qualitative representation, not drawn to scale)
1H2023
STRATEGIC KIPs ACHIEVEMENTS – 1H2023
7.0 €
| • | Data Monetization Revenues | +73% |
|---|---|---|
| • | ML Model Serving Revenues | +81% |
REVENUES (MLN)
+29% YoY organic growth on a like-for-like basis and with a new revenue strategy
CHURN RATE
affected by new revenue strategy
INFORMATION, DATA, PRICES, AND ANY AND ALL OTHER ECONOMIC, COMMERCIAL AND/OR MANAGEMENT INFORMATION (THE SO CALLED "CONFIDENTIAL INFORMATION") CONTAINED IN THE FOLLOWING PAGES ARE STRICTLY PRIVATE AND CONFIDENTIAL AND – TOGETHER WITH ALL TRADEMARKS, DESIGNS AND NAMES - ARE THE EXCLUSIVE PROPERTY OF DATRIX S.P.A.
CONFIDENTIAL INFORMATION CONTAINED IN THE FOLLOWING PAGES ARE FOR THE EXCLUSIVE AND PERSONAL USE OF THE ADDRESSEE, WHERE NOT OTHERWISE SPECIFIED, AND ARE SHARED ONLY FOR THE PURPOSES AGREED WITH DATRIX S.P.A. ANY REPRODUCTION, DISCLOSURE, USE, TRANSMISSION AND DISSEMINATION OF CONFIDENTIAL INFORMATION TO THIRD PARTIES WITHOUT A PRIOR WRITTEN AUTHORIZATION OF DATRIX S.P.A. IS STRICTLY PROHIBITED.
THE ADDRESSEE MUST KEEP THE CONFIDENTIAL INFORMATION STRICTLY RESERVED AND WILL IMPLEMENT AND OBSERVE ALL REASONABLE PRECAUTIONS AND MEASURES TO SAFEGUARD THE SECRECY AND CONFIDENTIALITY OF THE CONFIDENTIAL INFORMATION AND TO AVOID THEIR, EVEN PARTIAL, DISCLOSURE, PUBLICATION OR COMMUNICATION TO THIRD PARTIES WITHOUT A PRIOR WRITTEN AUTHORIZATION FROM DATRIX S.P.A. NOTHING CONTAINED IN THIS DOCUMENT SHOULD BE CONSTRUED AS INVESTMENT ADVICE AND ANY REFERENCE TO AN INVESTMENT'S PAST OR POTENTIAL PERFORMANCE IS NOT, AND SHOULD NOT BE CONSTRUED AS, A RECOMMENDATION OR AS A GUARANTEE OF ANY SPECIFIC OUTCOME OR PROFIT.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.